SymBiosis Capital Partners, LLC

Position in EVMN — Evommune, Inc.

CIK 2006045 BENTONVILLE, AR

Position in EVMN

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$29,445,086

+$7,518,167 QoQ

Shares Held

1,280,778

0.0% QoQ

Ownership

3.56%

of shares outstanding

% of Portfolio

55.80%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SymBiosis Capital Partners, LLC holds $50,642,960 across 4 Biotechnology names. EVMN ranks #1 (58.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EVMN	Evommune, Inc. This page	1,280,778	$29,445,086
2	IVA	Inventiva S.A.	2,354,000	$13,064,700
3	WVE	Wave Life Sciences Ltd.	750,000	$5,437,500
4	RANI	Rani Therapeutics Holdings, Inc.	3,667,585	$2,695,674

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$29,445,086	1,280,778	0.0%	Shares	Sole	2026-05-12
2025-12-31	$21,926,919	1,280,778	—	Shares	Sole	2026-02-12
No filing history on record for this holder in this stock.